In last trading session, Mesoblast Ltd ADR (NASDAQ:MESO) saw 0.39 million shares changing hands with its beta currently measuring 3.38. Company’s recent per share price level of $20.14 trading at $0.62 or 3.18% at ring of the bell on the day assigns it a market valuation of $2.56B. That closing price of MESO’s stock is at a discount of -9.24% from its 52-week high price of $22.00 and is indicating a premium of 91.31% from its 52-week low price of $1.75. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.37 million shares which gives us an average trading volume of 471.91K if we extend that period to 3-months.
For Mesoblast Ltd ADR (MESO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 10 analysts covering the stock, 2 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Mesoblast Ltd ADR (NASDAQ:MESO) trade information
Upright in the green during last session for gaining 3.18%, in the last five days MESO remained trading in the green while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $20.14 price level, adding 4.1% to its value on the day. Mesoblast Ltd ADR’s shares saw a change of 1.72% in year-to-date performance and have moved 10.24% in past 5-day. Mesoblast Ltd ADR (NASDAQ:MESO) showed a performance of 10.11% in past 30-days. Number of shares sold short was 1.86 million shares which calculate 2.25 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 12 to the stock, which implies a fall of -67.83% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would jump 40.42% in reaching the projected high whereas dropping to the targeted low would mean a gain of 40.42% for stock’s current value.
Mesoblast Ltd ADR (MESO) estimates and forecasts
Statistics highlight that Mesoblast Ltd ADR is scoring comparatively higher than the scores of other players of the relevant industry. The company added 196.61% of value to its shares in past 6 months, showing an annual growth rate of 16.85% while that of industry is 16.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to rise 951.14% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 2.39M for the same. And 1 analysts are in estimates of company making revenue of 2.49M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.34% during past 5 years.
Mesoblast Ltd ADR (NASDAQ:MESO)’s Major holders
GROUP ONE TRADING, L.P. is the top institutional holder at MESO for having 0.23 million shares of worth $1.55 million. And as of 2024-06-30, it was holding 0.2308 of the company’s outstanding shares.
The second largest institutional holder is SUSQUEHANNA INTERNATIONAL GROUP, LLP, which was holding about 0.15 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.1518 of outstanding shares, having a total worth of $1.02 million.
On the other hand, Trust for Professional Managers-ActivePassive International Equity ETF and Advisors Preferred Tr-Quantified Global Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024 , the former fund manager was holding 27.78 shares of worth $0.56 million or 0.02% of the total outstanding shares. The later fund manager was in possession of 6.4 shares on Sep 30, 2024 , making its stake of worth around $0.13 million in the company or a holder of 0.01% of company’s stock.
